HIKAL LTD
HIKAL LTD (India) holds 34 active US FDA Type II Drug Master Files and 6 inactive, has DMF or CEP filings on record for 35 active ingredients and is linked to 2 FDA-registered manufacturing sites. 1 FDA enforcement record is linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “HIKAL LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/hikal-ltd
Overview
HIKAL LTD is an active pharmaceutical ingredient (API) supplier with 34 active FDA Type II Drug Master Files, covering APIXABAN; BUPROPION HYDROBROMIDE (FORM II); BUPROPION HYDROBROMIDE (FORM-I); BUPROPION HYDROCHLORIDE USP; BUPROPION HYDROCHLORIDE USP [PROCESS-2]; BUTORPHANOL TARTRATE USP.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which HIKAL LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
HIKAL LTD holds 34 active (40 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- VONOPRAZAN FUMARATEActive2026-03-31
- CARIPRAZINE HYDROCHLORIDEActive2026-03-30
- EDOXABAN TOSYLATE MONOHYDRATEActive2024-09-30
- DABIGATRAN ETEXILATE MESILATEActive2024-06-29
- RIVAROXABAN USPActive2023-08-18
- BUPROPION HYDROBROMIDE (FORM II)Active2023-05-29
- BUPROPION HYDROBROMIDE (FORM-I)Active2023-03-24
- DESVENLAFAXINE SUCCINATE USPActive2022-08-20
- SITAGLIPTIN HYDROCHLORIDE (PROCESS B)Active2022-06-30
- ERTUGLIFLOZIN L-PYROGLUTAMIC ACIDActive2020-05-01
- SITAGLIPTIN PHOSPHATE ANHYDRATEActive2020-03-28
- EMPAGLIFLOZINActive2018-09-12
- DAPAGLIFLOZIN (DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE)Active2018-04-30
- APIXABANActive2017-12-29
- CELECOXIBActive2017-07-29
- BUTORPHANOL TARTRATE USPActive2017-06-29
- SITAGLIPTIN PHOSPHATE MONOHYDRATE (PROCESS-B)Active2017-03-17
- VALACYCLOVIR HYDROCHLORIDE USPActive2016-03-29
- LACOSAMIDE USPActive2016-02-25
- VILDAGLIPTINActive2015-10-14
- PREGABALIN (PROCESS-II)Active2015-08-12
- PREGABALIN USPActive2014-09-19
- BUPROPION HYDROCHLORIDE USP [PROCESS-2]Active2014-06-21
- GABEPENTIN (A01804)Active2014-05-24
- QUETIAPINE FUMARATE (PROCESS-B) USPActive2010-08-18
- MEMANTINE HYDROCHLORIDE USPActive2010-02-22
- VENLAFAXINE HYDROCHLORIDE USPActive2009-07-18
- TRIPROLIDINE HYDROCHLORIDE USPActive2005-12-08
- GEMFIBROZIL APIActive2005-09-15
- ONDANSETRON USPActive2005-09-03
- ONDANSETRON HYDROCHLORIDE USPActive2003-07-15
- BUPROPION HYDROCHLORIDE USPActive2003-03-13
- GABAPENTIN USPActive2002-07-24
- PENTOXIFYLLINE USPActive1999-06-01
- FAVIPIRAVIRInactive2021-03-27
- DABIGATRAN ETEXILATE MESYLATEInactive2017-03-25
- OLMESARTAN MEDOXOMIL USPInactive2016-03-22
- VENLAFAXINE BASEInactive2014-02-18
- DONEPEZIL HYDROCHLORIDE APIInactive2013-09-30
- LEVETIRACETAM APIInactive2006-01-10
Registered manufacturing sites (2)
Physical sites registered with the US FDA and resolved to HIKAL LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
1 FDA enforcement record linked to this company.
- warning_letter2025-08-20
FDA Warning Letter (drug product)
Is this HIKAL LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.